Encana Announces Early Tender Results and Increase in the

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Encana Announces Early Tender Results and Increase in the Aggregate Maximum Tender Amount

CALGARY, AB --(Marketwired - March 30, 2016) -  ( TSX : ECA ) ( NYSE : ECA )

Encana Corporation ("Encana" or the "Company") today announced the early tender results of its previously announced offers to purchase for cash (collectively, the "Tender Offers" and each a "Tender Offer") its outstanding senior notes listed in the table below (collectively, the "Notes"). The Company further announced that it has increased the aggregate amount that holders of the Notes are entitled to receive in the Tender Offers, excluding accrued and unpaid interest, from $250,000,000 to $400,000,000 (the "Aggregate Maximum Tender Amount"). Except for such increase in the Aggregate Maximum Tender Amount, all other terms and conditions of the Tender Offers remain unchanged. The Tender Offers are being made pursuant to the Company's Offer to Purchase dated March 16, 2016 (the "Offer to Purchase") and the related Letter of Transmittal (together with the Offer to Purchase, the "Offer Documents"), which set forth in detail the terms and conditions of the Tender Offers.

The aggregate principal amounts of Notes validly tendered at or prior to 5:00 p.m., New York City time, on March 29, 2016 (the "early tender date") are specified in the table below.

                             
Title of Notes   CUSIP Number   Principal Amount Outstanding   Acceptance Priority Level   Aggregate Principal Amount Tendered   Aggregate Principal Amount Accepted   Approximate Proration Factor   Total Consideration  (per $1,000 Principal  Amount of Notes Accepted)
5.15% Senior Notes due 2041   292505AK0   $400,000,000   1   $156,026,000   $156,026,000   100%   $750.00
6.50% Senior Notes due 2038   292505AG9   $800,000,000   2   $295,181,000   $295,181,000   100%   $850.00
6.625% Senior Notes due 2037   292505AE4   $500,000,000   3   $120,427,000   $37,737,000   31.3%   $850.00
6.50% Senior Notes due 2034   292505AD6   $750,000,000   4   $196,172,000   $0   0%   $850.00
                             

As a result of the increase in the Aggregate Maximum Tender Amount, and in accordance with the acceptance priority levels specified in the table above and on the cover page of the Offer to Purchase, (i) all the 5.15% Senior Notes due 2041 and 6.50% Senior Notes due 2038 that were validly tendered at or prior to the early tender date will be accepted for purchase by the Company on March 30, 2016 (the "early settlement date"), (ii) the 6.625% Senior Notes due 2037 that were validly tendered at or prior to the early tender date will be prorated (at an approximate proration factor as specified in the table above) and accepted for purchase by the Company on the early settlement date and (iii) none of the 6.50% Senior Notes due 2034 that were validly tendered at or prior to the early tender date will be accepted for purchase by the Company. The Company reserves the right, but is under no obligation, to further increase the Aggregate Maximum Tender Amount at any time, subject to applicable law. If the Company further increases the Aggregate Maximum Tender Amount, it does not expect to extend the withdrawal deadline, which expired at 5:00 p.m., New York City time, on March 29, 2016 (the "withdrawal deadline"), subject to applicable law. Therefore, any Notes tendered prior to or after the withdrawal deadline may not be withdrawn unless otherwise required by applicable law.

The consideration for each $1,000 principal amount of Notes validly tendered and accepted for purchase on the early settlement date pursuant to the Tender Offers will be the applicable Total Consideration set forth in the table above, which includes an early tender premium of $30 per $1,000 principal amount of Notes accepted for purchase. All Notes validly tendered and accepted for purchase on the early settlement date will also receive accrued and unpaid interest on such Notes from the last interest payment date with respect to those Notes to, but not including, the early settlement date. All Notes purchased in the Tender Offers will be retired and cancelled by the Company.

The Tender Offers will expire at 12:00 midnight, New York City time, on April 12, 2016 (one minute after 11:59 p.m., New York City time, on April 12, 2016), unless extended by the Company (the "expiration date"). Unless the Company further increases the Aggregate Maximum Tender Amount prior to the expiration date, no Notes tendered after the early tender date will be accepted for purchase pursuant to the Tender Offers. If the Company further increases the Aggregate Maximum Tender Amount, the Company will purchase any Notes that have been validly tendered in the Tender Offers at or prior to the expiration date promptly following the expiration date, subject to the acceptance priority level, Aggregate Maximum Tender Amount, proration and other terms and conditions of the Tender Offers. The final settlement date, if any, is expected to occur on the first business day following the expiration date.

The Company's obligation to accept for purchase, and to pay for, Notes validly tendered in the Tender Offers is subject to, and conditioned upon, the satisfaction or waiver of certain conditions described in the Offer Documents.

The Company is funding the Tender Offers, including accrued and unpaid interest and fees and expenses payable in connection with the Tender Offers, with cash on hand and borrowings under its revolving credit facility.

Citigroup Global Markets Inc. ("Citigroup") and Mitsubishi UFJ Securities (USA), Inc. ("MUFG") are the Dealer Managers in the Tender Offers. Global Bondholder Services Corporation is the Depositary and Information Agent for the Tender Offers. Persons with questions regarding the Tender Offers should contact Citigroup at (toll free) (800) 558-3745 or (collect) (212) 723-6106 or MUFG at (toll free) (877) 744-4532 or (collect) (212) 405-7481. Request for the Offer Documents should be directed to Global Bondholder Services Corporation at (toll free) (866) 470-4300 or (collect) (212) 430-3774.

This news release shall not constitute an offer to sell, a solicitation to buy or an offer to purchase or sell any securities. The Tender Offers are being made only pursuant to the Offer Documents and only in such jurisdictions as is permitted under applicable law. In any jurisdiction in which the Tender Offers are required to be made by a licensed broker or dealer, the Tender Offers will be deemed to be made on behalf of the Company by the Dealer Managers, or one or more registered brokers or dealers that are licensed under the laws of such jurisdiction.

All dollar amounts in this news release are expressed in U.S. dollars.

DISCLAIMER

This news release must be read in conjunction with the Offer Documents. This news release and the Offer Documents contain important information which must be read carefully before any decision is made with respect to the Tender Offers. If any holder of Notes is in any doubt as to the action it should take, it is recommended to seek its own legal, tax, accounting and financial advice, including as to any tax consequences, immediately from its stockbroker, bank manager, attorney, accountant or other independent financial or legal adviser. Any individual or company whose Notes are held on its behalf by a broker, dealer, bank, custodian, trust company or other nominee or intermediary must contact such entity if it wishes to participate in the Tender Offers. None of the Company, its Board of Directors, the Dealer Managers, the Depositary and Information Agent, the trustee with respect to the Notes, or any of the Company's or their respective affiliates, is making any recommendation as to whether holders should tender any Notes in response to the Tender Offers. Holders must make their own decision as to whether to participate in the Tender Offers, and, if so, the principal amount of Notes to tender.

Encana Corporation

Encana Corporation is a leading North American energy producer that is focused on developing its strong portfolio of resource plays, held directly and indirectly through its subsidiaries, producing natural gas, oil and natural gas liquids. By partnering with employees, community organizations and other businesses, Encana contributes to the strength and sustainability of the communities where it operates. Encana common shares trade on the Toronto and New York stock exchanges under the symbol ECA.

ADVISORY REGARDING FORWARD-LOOKING STATEMENTS - This news release contains certain forward-looking statements or information within the meaning of applicable securities legislation. Forward-looking statements include: statements regarding the terms and timing for completion of the Tender Offers, including the acceptance for purchase of any Notes validly tendered and the expected expiration date and final settlement date thereof; any potential additional increase to the Aggregate Maximum Tender Amount; the withdrawal deadline will not be extended; and the satisfaction or waiver of certain conditions of the Tender Offers.

Readers are cautioned against unduly relying on forward-looking statements which, by their nature, involve numerous assumptions, risks and uncertainties that may cause such statements not to occur, or results to differ materially from those expressed or implied. Risks and uncertainties that may affect these business outcomes include: risks related to the successful consummation of the Tender Offers; risk and effect of a downgrade in the Company's credit rating, including below an investment-grade credit rating, and its impact on access to capital markets and other sources of liquidity; fluctuations in currency and interest rates; changes in or interpretation of laws or regulations; and other risks and uncertainties impacting the Company's business as described from time to time in its most recent management discussion and analysis, financial statements, Annual Information Form and Form 40-F, as filed on SEDAR and EDGAR.

Although the Company believes the expectations represented by such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned that the assumptions, risks and uncertainties referenced above are not exhaustive. Forward-looking statements are made as of the date of this document and, except as required by law, the Company undertakes no obligation to update publicly or revise any forward-looking statements. The forward-looking statements contained in this document are expressly qualified by these cautionary statements.

SOURCE: Encana Corporation

Further information on Encana Corporation is available on the company's website, www.encana.com , or by contacting: Investor contact: Brendan McCracken Vice-President, Investor Relations (403) 645-2978 Brendan.McCracken@encana.com Patti Posadowski (403) 645-2252 Patti.Posadowski@encana.com Media contact:   Simon Scott  Vice-President, Communications  (403) 645-2526 Simon.Scott@encana.com Jay Averill  Director, Media Relations  (403) 645-4747 Jay.Averill@encana.com Doug McIntyre  Sr. Advisor, Media Relations  (403) 645-6553 Doug.McIntyre@encana.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NextPatient’s KLAS Marks Signal Specialty Workflow Fit

Updated Category News Views 22

A 93.3 score in healthcare software deserves a second look. Not a victory lap, not a drumroll—just a serious look at whether the product is solving an annoying, expensive operational problem for specialty practices. NextPatient’s recognition in the 2026 KLAS Emerging Solutions Top 20 Report lands in that category. The company placed in the top five for improving...

Continue Reading
Bank of America AML Claims Put Controls Under Fire

Updated Category News Views 157

A $1.2 billion compliance bill has a way of making investors stop pretending controls are boring. Moore Law PLLC is urging Bank of America shareholders to contact the firm over allegations tied to the bank's anti-money-laundering and Bank Secrecy Act systems. The notice follows what it describes as landmark October 13, 2026 enforcement actions by the Treasury Department's...

Continue Reading
Azazie Tests Bridal Demand With Two East Coast Pop-Ups

Updated Category News Views 127

Wedding dresses are a miserable product to buy sight unseen, no matter how pretty the product photos look. That basic fact is why Azazie’s two East Coast pop-ups on November 21 and 22 deserve a closer look. This is not some grand retail rollout, and nobody should pretend a pair of short events rewrites the bridal market. But it is a practical test of where a...

Continue Reading
Seeking Alpha Premium Review: Data Meets Human Judgment

Updated Category News Views 64

A spreadsheet can spot a cracked windshield, but it cannot tell you where the truck is headed. That is the useful, slightly irritating truth behind Seeking Alpha Premium’s 2026 pitch: it puts an enormous amount of stock-research machinery in one place, yet the investor still has to do the driving. Software Experts has highlighted the service in its review of...

Continue Reading
Suntory Flowers Tests NASCAR as a Garden Retail Engine

Updated Category News Views 130

Orange sheet metal and flowering vines are an odd couple, which is precisely why this South Florida promotion has some bite. A plant marketer took a hard left turn Suntory Flowers put its Sun Parasol mandevillas alongside DGM Racing at Homestead-Miami Speedway, celebrating the millions of plants grown in South Florida. That is not a conventional horticulture play, and...

Continue Reading
COPD Support Program Targets a Costly Care Gap Today

Updated Category News Views 24

Breathing trouble gets shrugged off far too easily, and that casual mistake has consequences. World COPD Day puts chronic obstructive pulmonary disease back in view, with the American Lung Association emphasizing a free Lung Health Navigator program for people living with COPD, their caregivers and families. This is not flashy medicine or a miracle-cure pitch. It is...

Continue Reading
Paratus on the Move: Seagems JV Under the Microscope

Updated Category News Views 194

What's Cooking with Paratus Energy? Paratus Energy Services Ltd. (ticker: PLSV) just threw us a curveball, announcing a strategic review of its participation in the Seagems joint venture. Now, before you get too jazzed about ticker talk—hold your horses. No one's making any promises about transactions just yet. The decision's still hanging in the balance, even as they...

Continue Reading
Yatsen’s November 25 Report Is the Real Beauty Test

Updated Category News Views 0

Beauty shelves can hide a lot of sins, but earnings day tends to drag them into fluorescent light. Yatsen will release unaudited third-quarter 2026 financial results before the U.S. market opens on Wednesday, November 25, then management will take questions at 7:30 a.m. Eastern Time. For anyone following NYSE:YSG, this is not a results story yet. It is a calendar marker,...

Continue Reading
Utility Global’s India Steel Move Needs Hard Numbers

Updated Category News Views 104

Steel decarbonization announcements can sound enormous before a single bolt gets tightened. Utility Global says it plans to deploy its first industrial H2Gen project in India with Tata Steel, and that is plainly worth watching. Tata Steel is a serious industrial name, India is a consequential steel market, and any technology that can credibly lower emissions from heavy...

Continue Reading
Vector's Peptide Pact Needs Proof Before Any Payday

Updated Category News Views 78

A famous orthopedic name can open doors, but it cannot manufacture clinical evidence. That is the plain reality behind Vector Science and Therapeutics' new collaboration with the Andrews Research & Education Foundation. Dr. James Andrews carries enormous credibility in sports medicine, earned across more than five decades of work. For Vector, that association matters. For...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Innovations in Cannabinoid Medicine at Avicanna's Symposium

Updated Category News Views 131

Avicanna's 5th Medical Symposium on Cannabinoid Medicine On June 6, a well-anticipated medical symposium will be hosted by Avicanna Inc., a prominent biopharmaceutical company dedicated to the innovative exploration of cannabinoid-based medicine. This exciting event, taking place at the MaRS Discovery District, aims to bring together healthcare practitioners and...

Continue Reading
Gordian's Exciting New Initiative for Public Facility Planning

Updated Category News Views 277

Gordian's New Sourcewell Contract Gordian, a well-known provider of data-driven solutions for various phases of the building lifecycle, has recently secured a significant contract with Sourcewell. This partnership will broaden Gordian’s offerings to numerous government and educational organizations eager to enhance their facility planning capabilities. Facilitating...

Continue Reading
Paramount Global CFO Transition: A New Era Begins

Updated Category News Views 251

Paramount Global Announces Significant Leadership Change Paramount Global (NASDAQ: PARA) has made a noteworthy announcement regarding its executive leadership. Naveen Chopra, who has been serving as the Chief Financial Officer and Executive Vice President, will be departing from the company to explore new opportunities. The company's Board of Directors has stated that...

Continue Reading
Explore the Potential of Axsome, CRISPR, and Pfizer Stocks

Updated Category News Views 134

Back in 2023, the stock market was a mixed bag, with plenty of sectors showing serious signs of overvaluation. You had legends like Warren Buffett sitting on a mountain of cash, clearly indicating he saw overpriced stocks everywhere. When seasoned investors hit the brakes on buying due to high valuations, it’s like an alarm bell for everyone else—caution was in the...

Continue Reading
Boeing's Production Delays and Its Impact on Suppliers

Updated Category News Views 245

A Closer Look at Boeing's Production Setbacks Boeing Co has recently notified its suppliers about a significant change to a key production milestone for its 737 MAX aircraft. This adjustment, which extends the timeline by six months, has raised concerns within the aviation industry. Sources indicate that the new objective is to achieve an output of 42 jets per month by...

Continue Reading